Development and Clinical Validation of a Simultaneous Ultra‐High‐Performance Liquid Chromatography Tandem Mass Spectrometry Assay for Three Triazole Antifungal Agents and Two Metabolites Enabling Precision Therapeutic Drug Monitoring in Chinese Patients With Hematologic Malignancies

Ejemplares similares

• Simultaneous Determination of Multiple Anti‐Seizure Medications in Human Plasma Using High‐Performance Liquid Chromatography‐Tandem Mass Spectrometry with Positive/Negative Ion‐Switching Ionization Mode for Therapeutic Drug Monitoring
  por: Yu‐Fei Zhang, et al.
  Publicado: (2025)
• Simultaneous Multiclass Analysis of Cyanotoxins in Cyanobacterial Samples Using Hydrophilic Interaction Liquid Chromatography‐Tandem Mass Spectrometry
  por: Rosemary Bergin, et al.
  Publicado: (2025)
• High‐Performance Liquid Chromatography–Tandem Mass Spectrometry Method Development and Validation for Simultaneous Determination of Seven Nitrosamine and Azidomethyl‐Biphenyl‐Tetrazole Impurities in Losartan
  por: Nguyen Minh Luan, et al.
  Publicado: (2024)
• Enhanced Lipidomics Analysis of Breast Cancer Cells Using Three‐phase Liquid Extraction and Ultra High‐performance Liquid Chromatography Coupled With Quadrupole Time‐of‐Flight Tandem Mass Spectrometry
  por: Binhong He, et al.
  Publicado: (2024)
• Rapid Identification of Chemical Constituents of Sanhua Decoction in Vivo and in Vitro and the Metabolites of Rhubarb Anthraquinone Aglycone by Ultra‐High Performance Liquid Chromatography Coupled with Quadrupole Time‐of‐Flight Tandem Mass Spectrometry
  por: Xiang Wang, et al.
  Publicado: (2024)